The NHS has raised concerns regarding a widely used pain relief medication in the UK. Each year, millions of prescriptions for co-codamol are distributed, including over 650,000 prescriptions from pharmacists in addition to those prescribed by doctors.
Although GPs and pharmacists provide guidance on the duration of co-codamol use, individuals purchasing the medication from a pharmacy are cautioned against prolonged consumption. Low-dose co-codamol is obtainable over the counter at pharmacies.
According to the NHS advisory, individuals who obtain co-codamol from a pharmacy are advised not to exceed a three-day usage period. Prolonged use of co-codamol may lead to codeine tolerance, necessitating higher doses for pain management over time.
Additionally, extended use of co-codamol may result in heightened pain sensitivity (hyperalgesia) and potential codeine addiction. Patients are urged to regularly review their dosage with healthcare providers to ensure appropriate pain management.
Co-codamol is restricted or prohibited in certain countries due to its codeine content, classified as an opioid. Regulations on codeine control vary by location, with the USA and countries like Australia, Canada, New Zealand, and some European nations imposing restrictions on the availability of co-codamol.
Please note that by using our website and services, you consent to the use of cookies and agree to our Privacy Notice and Terms and Conditions.